Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Volpes

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|January 5, 1991
CD14 as marker for liver allograft rejection?R Volpes, J J van den Oord, B Van Damme, et al.
Clinical and Experimental Immunology|January 1, 1992
Induction of intercellular adhesion molecule-1 (CD54) on human hepatoma cell line HepG2: influence of cytokines and hepatitis B virus-DNA transfectionR Volpes, J J van den Oord, V J Desmet, et al.
Lancet (London, England)|February 18, 1989
Alpha-interferon and post-transfusion NANB hepatitisA Craxì, V Di Marco, R Volpes, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 3, 2009
Hepatitis C virus infection in a living-related liver donorS Gruttadauria, D Pagano, I Petridis, et al.
Endoscopy|January 30, 2009
Use of a self-expandable metallic stent for large bile leakage following orthotopic liver transplantM Di Pisa, M Traina, R Miraglia, et al.
Panminerva Medica|August 31, 2000
Hepatocellular carcinoma in a non-cirrhotic liver. Two case reports and literature reviewN Leone, R Volpes, M Carrera, et al.
Clinical Neurology and Neurosurgery|July 7, 2020
Acute and reversible Pisa syndrome as unusual presentation of portosystemic encephalopathyS Maccora, G Smorlesi, R Volpes, et al.
Endoscopy|February 23, 2012
Fully covered metallic stents in biliary stenosis after orthotopic liver transplantationI Tarantino, M Traina, F Mocciaro, et al.
Journal of Hepatology|March 1, 1991
Expression of interferon-gamma receptor in normal and pathological human liver tissueR Volpes, J J van den Oord, R De Vos, et al.
Journal of Hepatology|May 1, 1996
Transfusion-associated chronic hepatitis C: alpha-n1 interferon for 6 vs. 12 monthsA Craxì, V Di Marco, O Lo Iacono, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|January 5, 1991
CD14 as marker for liver allograft rejection?R Volpes, J J van den Oord, B Van Damme, et al.
Clinical and Experimental Immunology|January 1, 1992
Induction of intercellular adhesion molecule-1 (CD54) on human hepatoma cell line HepG2: influence of cytokines and hepatitis B virus-DNA transfectionR Volpes, J J van den Oord, V J Desmet, et al.
Lancet (London, England)|February 18, 1989
Alpha-interferon and post-transfusion NANB hepatitisA Craxì, V Di Marco, R Volpes, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 3, 2009
Hepatitis C virus infection in a living-related liver donorS Gruttadauria, D Pagano, I Petridis, et al.
Endoscopy|January 30, 2009
Use of a self-expandable metallic stent for large bile leakage following orthotopic liver transplantM Di Pisa, M Traina, R Miraglia, et al.
Panminerva Medica|August 31, 2000
Hepatocellular carcinoma in a non-cirrhotic liver. Two case reports and literature reviewN Leone, R Volpes, M Carrera, et al.
Clinical Neurology and Neurosurgery|July 7, 2020
Acute and reversible Pisa syndrome as unusual presentation of portosystemic encephalopathyS Maccora, G Smorlesi, R Volpes, et al.
Endoscopy|February 23, 2012
Fully covered metallic stents in biliary stenosis after orthotopic liver transplantationI Tarantino, M Traina, F Mocciaro, et al.
Journal of Hepatology|March 1, 1991
Expression of interferon-gamma receptor in normal and pathological human liver tissueR Volpes, J J van den Oord, R De Vos, et al.
Journal of Hepatology|May 1, 1996
Transfusion-associated chronic hepatitis C: alpha-n1 interferon for 6 vs. 12 monthsA Craxì, V Di Marco, O Lo Iacono, et al.
Pageof 5